GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » The Cigna Group (NYSE:CI) » Definitions » Sloan Ratio %
中文

The Cigna Group (The Cigna Group) Sloan Ratio % : -0.97% (As of Dec. 2023)


View and export this data going back to 1982. Start your Free Trial

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

The Cigna Group's Sloan Ratio for the quarter that ended in Dec. 2023 was -0.97%.

As of Dec. 2023, The Cigna Group has a Sloan Ratio of -0.97%, indicating the company is in the safe zone and there is no funny business with accruals.


The Cigna Group Sloan Ratio % Historical Data

The historical data trend for The Cigna Group's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Cigna Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.34 -3.13 1.16 -3.51 -0.97

The Cigna Group Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.51 -3.59 -4.44 -1.18 -0.97

Competitive Comparison

For the Healthcare Plans subindustry, The Cigna Group's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Cigna Group Sloan Ratio % Distribution

For the Healthcare Plans industry and Healthcare sector, The Cigna Group's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where The Cigna Group's Sloan Ratio % falls into.



The Cigna Group Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

The Cigna Group's Sloan Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2023 )-Cash Flow from Operations (A: Dec. 2023 )
-Cash Flow from Investing (A: Dec. 2023 ))/Total Assets (A: Dec. 2023 )
=(5164-11813
--5174)/152761
=-0.97%

The Cigna Group's Sloan Ratio for the quarter that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2023 )
=(5164-11813
--5174)/152761
=-0.97%

The Cigna Group's Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was 1267 (Mar. 2023 ) + 1460 (Jun. 2023 ) + 1408 (Sep. 2023 ) + 1029 (Dec. 2023 ) = $5,164 Mil.
The Cigna Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 was 5028 (Mar. 2023 ) + 2492 (Jun. 2023 ) + 2826 (Sep. 2023 ) + 1467 (Dec. 2023 ) = $11,813 Mil.
The Cigna Group's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 was -2983 (Mar. 2023 ) + -414 (Jun. 2023 ) + -1337 (Sep. 2023 ) + -440 (Dec. 2023 ) = $-5,174 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Cigna Group  (NYSE:CI) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2023, The Cigna Group has a Sloan Ratio of -0.97%, indicating the company is in the safe zone and there is no funny business with accruals.


The Cigna Group Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of The Cigna Group's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


The Cigna Group (The Cigna Group) Business Description

Address
900 Cottage Grove Road, Bloomfield, CT, USA, 06002
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense and it recently won a deal with top-tier insurer Centene. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 18 million U.S. medical members covered as of the end of June 2023.
Executives
Cynthia Ryan officer: EVP, CHRO 1601 CHESTNUT STREET, SHAREHOLDER SERVICES TL05Z, PHILADELPHIA PA 19192
Nicole S Jones officer: EVP, General Counsel 1601 CHESTNUT STREET, SHAREHOLDER SERVICES TL18Y, PHILADELPHIA PA 19192
Agoglia Hoeltzel Mary T officer: VP & Chief Accounting Officer 1601 CHESTNUT STREET, TWO LIBERTY PLACE, PHILADELPHIA PA 19192
Brian C Evanko officer: President Government Business 1601 CHESTNUT STREET, SHAREHOLDER SERVICES TL05Y, PHILADELPHIA PA 19192
Everett Neville officer: EVP, Strategy and Business Dev ONE EXPRESS WAY, ST. LOUIS MO 63121
Paul A Sanford officer: EVP Operations 1601 CHESTNUT STREET, SHAREHOLDER SERVICES TL05Z, PHILADELPHIA PA 19192
Phillip Ozuah director 30 HUDSON STREET, FLOOR 33, JERSEY CITY NJ 07302
Donna F Zarcone director C/O HARLEY DAVIDSON, 3700 W. JUNEAU AVE, MILWAUKEE WI 53208
Michael W Triplett officer: President, US Markets 1601 CHESTNUT STREET, SHAREHOLDER SERVICES TL05Y, PHILADELPHIA PA 19192
Elder Granger director 5176 S. LEWISTON WAY, CENTENNIAL CO 80015
David Cordani director, officer: President & CEO THE CIGNA GROUP, 900 COTTAGE GROVE ROAD, BLOOMFIELD CT 06002
Jason D Sadler officer: Pres., International Markets 1601 CHESTNUT STREET, SHAREHOLDER SERVICES TL05Y, PHILADELPHIA PA 19192
Eric P Palmer officer: EVP, Chief Financial Officer 1601 CHESTNUT STREET, SHAREHOLDER SERVICES TL05Y, PHILADELPHIA PA 19192
David J Brailer officer: EVP & Chief Health Officer 4 PRESIDIO TERRACE, SAN FRANCISCO CA 94118
Charles Berg officer: Pres, Govt Programs & Sr Advsr 48 MONROE TURNPIKE, TRUMBULL CT 06611

The Cigna Group (The Cigna Group) Headlines